These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33844832)

  • 1. Co-pathologies in Alzheimer's disease: just multiple pathologies or partners in crime?
    Tomé SO; Thal DR
    Brain; 2021 Apr; 144(3):706-708. PubMed ID: 33844832
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia and detectives: Alzheimer's disease in crime fiction.
    Orr DM
    Dementia (London); 2020 Apr; 19(3):560-573. PubMed ID: 29807456
    [No Abstract]   [Full Text] [Related]  

  • 4. Are the brain's vascular and Alzheimer pathologies additive or interactive?
    Koncz R; Sachdev PS
    Curr Opin Psychiatry; 2018 Mar; 31(2):147-152. PubMed ID: 29232251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes.
    Brenowitz WD; Nelson PT; Besser LM; Heller KB; Kukull WA
    Neurobiol Aging; 2015 Oct; 36(10):2702-8. PubMed ID: 26239176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's pathology targets distinct memory networks in the ageing brain.
    Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
    Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons.
    Kapasi A; Schneider JA
    Biochim Biophys Acta; 2016 May; 1862(5):878-86. PubMed ID: 26769363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-6-phosphate dehydrogenase deficiency and Alzheimer's disease: Partners in crime? The hypothesis.
    Ulusu NN
    Med Hypotheses; 2015 Aug; 85(2):219-23. PubMed ID: 26004559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterogeneity of Alzheimer’s disease].
    Balázs N; Kovács T
    Orv Hetil; 2021 Jun; 162(25):970-977. PubMed ID: 34148025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of cerebral atrophy differ in different degenerative pathologies.
    Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
    Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropathological diagnosis of Alzheimer's disease.
    DeTure MA; Dickson DW
    Mol Neurodegener; 2019 Aug; 14(1):32. PubMed ID: 31375134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of multiple pathologies on the threshold for clinically overt dementia.
    Kapasi A; DeCarli C; Schneider JA
    Acta Neuropathol; 2017 Aug; 134(2):171-186. PubMed ID: 28488154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropathologic Aspects of Co-occurrence of Dementia with Lewy Bodies and Alzheimer's Disease].
    Takao M
    Brain Nerve; 2018 Aug; 70(8):905-913. PubMed ID: 30082500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples.
    Brenowitz WD; Keene CD; Hawes SE; Hubbard RA; Longstreth WT; Woltjer RL; Crane PK; Larson EB; Kukull WA
    Neurobiol Aging; 2017 May; 53():83-92. PubMed ID: 28236716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
    Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
    Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease.
    Mihardja M; Roy J; Wong KY; Aquili L; Heng BC; Chan YS; Fung ML; Lim LW
    Ann N Y Acad Sci; 2020 Oct; 1478(1):43-62. PubMed ID: 32700392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pinning the suspect to the crime in Alzheimer's.
    Finkel E
    Lancet; 1996 Nov; 348(9040):1506. PubMed ID: 8965592
    [No Abstract]   [Full Text] [Related]  

  • 19. Alzheimer's disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview.
    Matej R; Tesar A; Rusina R
    Clin Biochem; 2019 Nov; 73():26-31. PubMed ID: 31400306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease.
    Lai AY; McLaurin J
    J Neurochem; 2018 Mar; 144(5):659-668. PubMed ID: 28722749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.